Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)

Inclusion Criteria:

• Meet the diagnostic criteria of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood StasisSyndrome).
• Meet the diagnostic criteria of stable coronary heart disease, chronic insomnia,headache (Migraine without Aura and Tension-Type Headache ), or endometriosis, amongwhich:
• the score of angina pectoris frequency domain in SAQ ≤ 80 points in the patientswith stable coronary heart disease;
• Pittsburgh sleep quality index> 10 points in patients with chronic insomnia;
• Patients with migraine without aura have 3 or more attacks per month within 3months before enrollment;
• In patients with tension-Type headache, within 3 months before enrollment, thenumber of attack days per month is ≥ 2 days;
• The VAS score of the pain ≥ 40 points in patients with endometriosis;
• Patients with endometriosis diagnosed with any type of confirmed pathologicalreports(previous diagnosis is also possible).
• Patients were ≥18 and ≤75 years of age.
• Voluntarily provided written informed consent.

Exclusion Criteria:

• Patients with acute myocardial infarction, rapid atrial fibrillation, atrial flutter,paroxysmal ventricular tachycardia and other severe arrhythmias and severe cardiac andpulmonary insufficiency in the past 3 months
• Patients with acute cerebrovascular disease such as cerebral infarction and cerebralhemorrhage in the past 3 months;
• Those with poorly controlled hypertension (systolic blood pressure ≥160mmHg ordiastolic blood pressure ≥100mmHg after treatment);
• Patients with aortic dissection;
• Patients with abnormal liver and kidney function indicators (ALT, AST are 1.5 timesgreater than the upper limit of normal value, and Scr is greater than the upper limitof normal value);
• SAS≥70 points;
• SDS≥73 points;
• VAS≥80 points;
• Patients with severe primary heart, brain, liver, kidney, and hematopoietic diseases;
• Women during pregnancy and lactation;
• Those with cognitive impairment, consciousness impairment or mental illness, whocannot communicate normally;
• People with allergies, or those who are known to be allergic to the trial drug (including its components);
• Surgery(including intervention, radio frequency, etc.) during the past 4 weeks;
• Those with bleeding tendency;
• Those who suspect or have a history of alcohol or drug abuse;
• Participation in another trial in the past 1 month;
• Other circumstances judged by the researcher to be unsuitable for participation in thetrial.